- Supported exchanges /
- PINK /
- OCTHF.PINK
Oxford Cannabinoid Technologies Holdings Plc (OCTHF PINK) stock market data APIs
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase " I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
Oxford Cannabinoid Technologies Holdings Plc Financial Data Overview
0.0028 | |
0.0028 | |
- | |
0.0028 | |
0.0028 | |
0.0028-0.0443 | |
3 048 K | |
1 088 M | |
0 | |
4.094 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Oxford Cannabinoid Technologies Holdings Plc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -4 875 426
- Earnings Per Share -0.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Oxford Cannabinoid Technologies Holdings Plc Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Oxford Cannabinoid Technologies Holdings Plc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: